![Veracyte, Inc. logo](/logos/VCYT.webp)
Veracyte, Inc.
NASDAQ:VCYT
Overview | Financials
Company Name | Veracyte, Inc. |
Symbol | VCYT |
Currency | USD |
Price | 28.57 |
Market Cap | 2,194,521,697 |
Dividend Yield | 0% |
52-week-range | 18.61 - 33.33 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Marc A. Stapley |
Website | https://www.veracyte.com |
An error occurred while fetching data.
About Veracyte, Inc.
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD